| Human cytochrome b5 reductase: structure, function, and potential applications F Elahian, Z Sepehrizadeh, B Moghimi, SA Mirzaei Critical reviews in biotechnology 34 (2), 134-143, 2014 | 95 | 2014 |
| High-throughput bioaccumulation, biotransformation, and production of silver and selenium nanoparticles using genetically engineered Pichia pastoris F Elahian, S Reiisi, A Shahidi, SA Mirzaei Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 853-861, 2017 | 94 | 2017 |
| The anticancer agent prodigiosin is not a multidrug resistance protein substrate F Elahian, B Moghimi, F Dinmohammadi, M Ghamghami, M Hamidi, ... DNA and cell biology 32 (3), 90-97, 2013 | 74 | 2013 |
| siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells R Heidari, P Khosravian, SA Mirzaei, F Elahian Scientific reports 11 (1), 20531, 2021 | 41 | 2021 |
| Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines F Kalalinia, F Elahian, J Behravan Journal of cancer research and clinical oncology 137, 321-330, 2011 | 41 | 2011 |
| ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells SA Mirzaei, NG Dehkordi, M Ghamghami, AH Amiri, ED Abdolahinia, ... Toxicology and applied pharmacology 337, 22-29, 2017 | 40 | 2017 |
| Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells SA Mirzaei, S Reiisi, P Ghiasi Tabari, A Shekari, F Aliakbari, E Azadfallah, ... Scientific Reports 8 (1), 3446, 2018 | 37 | 2018 |
| Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines F Elahian, F Kalalinia, J Behravan Drug and chemical toxicology 33 (2), 113-119, 2010 | 34 | 2010 |
| Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines. F Elahian, F Kalalinia, J Behravan Oncology research 18 (1), 9-15, 2009 | 30 | 2009 |
| Inflammatory pathway interactions and cancer multidrug resistance regulation SA Mirzaei, F Dinmohammadi, A Alizadeh, F Elahian Life sciences 235, 116825, 2019 | 26 | 2019 |
| Genetically modified Pichia pastoris, a powerful resistant factory for gold and palladium bioleaching and nanostructure heavy metal biosynthesis F Elahian, R Heidari, VR Charghan, E Asadbeik, SA Mirzaei Artificial Cells, Nanomedicine, and Biotechnology 48 (1), 259-265, 2020 | 23 | 2020 |
| Celecoxib up regulates the expression of drug efflux transporter ABCG2 in breast cancer cell lines F Kalalinia, F Elahian, F Mosaffa, J Behravan Iranian Journal of Pharmaceutical Research: IJPR 13 (4), 1393, 2014 | 22 | 2014 |
| Phorbol ester TPA modulates chemoresistance in the drug sensitive breast cancer cell line MCF-7 by inducing expression of drug efflux transporter ABCG2 F Kalalinia, F Elahian, M Hassani, J Kasaeeian, J Behravan Asian Pacific Journal of Cancer Prevention 13 (6), 2979-2984, 2012 | 19 | 2012 |
| Intelligent TAT‐coupled anti‐HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma N Gholamian Dehkordi, F Elahian, P Khosravian, SA Mirzaei Journal of Cellular Physiology 234 (11), 20769-20778, 2019 | 17 | 2019 |
| The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells M Mansouri, SA Mirzaei, H Lage, SS Mousavi, F Elahian Biochimie 99, 71-76, 2014 | 15 | 2014 |
| Synthesis and anticancer activity of 2, 4, 5-triaryl imidazole derivatives F Elahian, M Akbari, M Ghasemi, N Behtooee, M Taheri, M Amini Letters in Drug Design & Discovery 11 (7), 840-843, 2014 | 13 | 2014 |
| Enhancing the therapeutic efficacy of daunorubicin and mitoxantrone with bavachinin, candidone, and tephrosin S Darzi, SA Mirzaei, F Elahian, S Shirian, A Peymani, B Rahmani, ... Evidence-Based Complementary and Alternative Medicine 2019, 2019 | 11 | 2019 |
| Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposomes to overcome multidrug resistance in breast cancer cells M Safaei, P Khosravian, SK Sheykhshabani, G Mardani, F Elahian, ... Toxicology and Applied Pharmacology 441, 115989, 2022 | 10 | 2022 |
| Ecotypic variations affected the biological effectiveness of Thymus daenensis Celak essential oil F Elahian, M Garshasbi, Z Mehri Asiabar, N Gholamian Dehkordi, ... Evidence-Based Complementary and Alternative Medicine 2021, 1-12, 2021 | 9 | 2021 |
| Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness N Gholamian Dehkordi, SA Mirzaei, F Elahian Inflammopharmacology 29 (1), 49-74, 2021 | 9 | 2021 |
Seyed Abbas MirzaeiShahrekord University of Medical SciencesVerified email at skums.ac.ir
